Google Health absorbs DeepMind

The team behind DeepMind’s Streams mobile app and AI medical research ventures is being absorbed back into Google, according to CNBC.

UK-based AI company DeepMind is a portfolio company by Alphabet, Google's parent company, and will now be a part of Google Health—the latest move by Alphabet to boost collaboration and communication across its various health projects, CNBC reported.

The DeepMind Health group will cease operating as an independent brand to become part of Google, and will continue health research with its academic partners. Its products will be deployed under the Google umbrella.

DeepMind' signature app Steams helps doctors spot kidney failure and other ailments. The move should help turn the Streams app into an AI-powered tool for doctors and nurses, DeepMind executives wrote in a recent blog post,

"Our vision is for Streams to now become an AI-powered assistant for nurses and doctors everywhere - combining the best algorithms with intuitive design, all backed up by rigorous evidence," executives wrote. "The team working within Google, alongside brilliant colleagues from across the organization, will help make this vision a reality."

The newly-formed Google Health team is led by David Feinberg, the former president and CEO of the Geisinger Health System.

To read the full report, click the link below.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”